|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
|
Nodular Sclerosis Classical Hodgkin Lymphoma
|
|
0.710 |
GeneticVariation
|
GWASCAT |
These SNPs are found on 2 haplotypes associated with NSHL risk (rs204999-rs9268528-rs9268542-rs6903608-rs2858870; AGGCT, OR = 1.7, P = 1.71 × 10(-6); GAATC, OR = 0.4, P = 1.16 × 10(-4)).
|
22086417 |
2012 |
|
Nodular Sclerosis Classical Hodgkin Lymphoma
|
|
0.710 |
GeneticVariation
|
BEFREE |
These SNPs are found on 2 haplotypes associated with NSHL risk (rs204999-rs9268528-rs9268542-rs6903608-rs2858870; AGGCT, OR = 1.7, P = 1.71 × 10(-6); GAATC, OR = 0.4, P = 1.16 × 10(-4)).
|
22086417 |
2012 |
|
Nodular Sclerosis Classical Hodgkin Lymphoma
|
|
0.710 |
GeneticVariation
|
GWASCAT |
These SNPs are found on 2 haplotypes associated with NSHL risk (rs204999-rs9268528-rs9268542-rs6903608-rs2858870; AGGCT, OR = 1.7, P = 1.71 × 10(-6); GAATC, OR = 0.4, P = 1.16 × 10(-4)).
|
22086417 |
2012 |
|
Graves Disease
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new risk loci for Graves' disease.
|
21841780 |
2011 |
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
|
Multiple Sclerosis
|
|
0.700 |
GeneticVariation
|
GWASDB |
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
|
20598377 |
2010 |
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation
|
GWASDB |
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
|
19503088 |
2009 |
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation
|
GWASDB |
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
|
17804836 |
2007 |
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
|
Adult Classical Hodgkin Lymphoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
For EBV-negative cHL the class II SNP rs6903608 remained the strongest predictor of disease risk after adjusting for the effects of common HLA alleles.
|
25648508 |
2015 |
|
Classical Hodgkin's Lymphoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
For EBV-negative cHL the class II SNP rs6903608 remained the strongest predictor of disease risk after adjusting for the effects of common HLA alleles.
|
25648508 |
2015 |
|
Classical Hodgkin's Lymphoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
The association between rs6903608 and EBV-negative cHL was confined to the nodular sclerosis histological subtype.
|
22286212 |
2012 |
|
Adult Classical Hodgkin Lymphoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
The association between rs6903608 and EBV-negative cHL was confined to the nodular sclerosis histological subtype.
|
22286212 |
2012 |
|
Thrombotic thrombocytopenic purpura, acquired
|
|
0.010 |
GeneticVariation
|
BEFREE |
Results and conclusion We identified one common variant (rs6903608</span>) located within the HLA class II locus that was independently associated with acquired TTP at genome-wide significance and conferred a 2.6-fold increased risk of developing a TTP episode (95% confidence interval [CI] 2.02-3.27, P = 1.64 × 10<sup>-14</sup> ).
|
27762046 |
2016 |
|
Congenital Thrombotic Thrombocytopenic Purpura
|
|
0.010 |
GeneticVariation
|
BEFREE |
Results and conclusion We identified one common variant (rs6903608) located within the HLA class II locus that was independently associated with acquired TTP at genome-wide significance and conferred a 2.6-fold increased risk of developing a TTP episode (95% confidence interval [CI] 2.02-3.27, P = 1.64 × 10<sup>-14</sup> ).
|
27762046 |
2016 |
|
Purpura, Thrombotic Thrombocytopenic
|
|
0.010 |
GeneticVariation
|
BEFREE |
Results and conclusion We identified one common variant (rs6903608) located within the HLA class II locus that was independently associated with acquired TTP at genome-wide significance and conferred a 2.6-fold increased risk of developing a TTP episode (95% confidence interval [CI] 2.02-3.27, P = 1.64 × 10<sup>-14</sup> ).
|
27762046 |
2016 |